Showing results (11-20 of 79) with videos related to

Sort By:
Pageof 8
Journal of Neuroscience Research|March 14, 2002
Role of CB1 and CB2 receptors in the inhibitory effects of cannabinoids on lipopolysaccharide-induced nitric oxide release in astrocyte culturesFrancisco Molina-Holgado, Eduardo Molina-Holgado, Carmen Guaza, et al.
Frontiers in Cellular Neuroscience|March 7, 2020
Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-ReviewMiriam Mecha, Francisco J Carrillo-Salinas, Ana Feliú, et al.
Progress in Neurobiology|December 4, 2012
Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virusMiriam Mecha, Francisco J Carrillo-Salinas, Leyre Mestre, et al.
Expert Opinion on Therapeutic Targets|January 23, 2008
Therapeutic potential of CB2 targeting in multiple sclerosisFabian Docagne, Leyre Mestre, Frida Loría, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 16, 2002
Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophreniaJosé Borrell, José Miguel Vela, Angel Arévalo-Martin, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 10, 2003
Therapeutic action of cannabinoids in a murine model of multiple sclerosisAngel Arévalo-Martín, José Miguel Vela, Eduardo Molina-Holgado, et al.
Regulatory Peptides|July 6, 2005
Nitric oxide released by accessory cells mediates the gastrin-releasing peptide effect on murine lymphocyte chemotaxisSonia Medina, Mónica Del Rio, Angel Hernanz, et al.
Pageof 8